B. 1. Takada, Y. , X. Ye, S. T. Simon, and . Integrins, The integrins, Genome Biology, vol.8, issue.5, p.215, 2007.
DOI : 10.1186/gb-2007-8-5-215

J. Bell, J. Dedhar, and S. , Regulation of Cell Adhesion and Anchorage-dependent Growth by a New Beta 1-integrin-linked Protein Kinase, Nature, vol.379, issue.6560, pp.91-96, 1996.

G. Curley, H. Blum, and M. Humphries, Integrin antagonists, Cellular and Molecular Life Sciences (CMLS), vol.56, issue.5-6, pp.5-6, 1999.
DOI : 10.1007/s000180050443

R. Hynes, Integrins, Cell, vol.110, issue.6, pp.673-687, 2002.
DOI : 10.1016/S0092-8674(02)00971-6

M. Barczyk, S. Carracedo, and D. Gullberg, Integrins, Cell and Tissue Research, vol.137, issue.1, pp.269-280, 2009.
DOI : 10.1002/(SICI)1097-0177(199612)207:4<355::AID-AJA1>3.0.CO;2-G

J. Takagi and T. Springer, Integrin activation and structural rearrangement, Immunological Reviews, vol.93, issue.1
DOI : 10.1074/jbc.273.44.28937

C. Rüegg and A. Mariotti, Vascular integrins: pleiotropic adhesion and signaling molecules in vascular homeostasis and angiogenesis, Cellular and Molecular Life Sciences, vol.60, issue.6, pp.1135-1157, 2003.
DOI : 10.1007/s00018-003-2297-3

J. Askari, P. Buckley, A. Mould, and M. Humphries, Linking integrin conformation to function, Journal of Cell Science, vol.122, issue.2, pp.165-170, 2009.
DOI : 10.1242/jcs.018556

URL : http://jcs.biologists.org/content/joces/122/2/165.full.pdf

S. Goodman and M. Arnaout, Crystal Structure of the Extracellular Segment of Integrin Alpha Vbeta3, Science, vol.294, issue.5541, pp.339-345, 2001.

J. Jones and R. Walker, Integrins: a role as cell signalling molecules, Molecular Pathology, vol.52, issue.4, pp.208-213, 1999.
DOI : 10.1136/mp.52.4.208

F. Watt, NEW EMBO MEMBER'S REVIEW: Role of integrins in regulating epidermal adhesion, growth and differentiation, The EMBO Journal, vol.21, issue.15, pp.3919-3926, 2002.
DOI : 10.1093/emboj/cdf399

A. Tiwari, J. Jung, S. Inamdar, C. Brown, A. Goel et al., Endothelial cell migration on fibronectin is regulated by syntaxin 6-mediated {alpha}5{beta}1 integrin recycling, The Journal of Biological Chemistry, 2011.

R. Zaidel-bar and B. Geiger, The switchable integrin adhesome, Journal of Cell Science, vol.123, issue.9, pp.1385-1388, 2010.
DOI : 10.1242/jcs.066183

E. Zamir and B. Geiger, Components of Cell-matrix Adhesions, Journal of Cell Science, vol.114, pp.3577-3579, 2001.

T. Pellinen and J. Ivaska, Integrin traffic, Journal of Cell Science, vol.119, issue.18, pp.3723-3731, 2006.
DOI : 10.1242/jcs.03216

URL : http://jcs.biologists.org/content/joces/119/18/3723.full.pdf

P. Caswell and J. Norman, Integrin Trafficking and the Control of Cell Migration, Traffic, vol.16, issue.Suppl. 1
DOI : 10.1091/mbc.10.1.47

G. Mizejewski, Role of Integrins in Cancer: Survey of Expression Patterns, Proceedings of the Society for Experimental Biology and Medicine, vol.222, issue.2
DOI : 10.1046/j.1525-1373.1999.d01-122.x

J. Desgrosellier and D. Cheresh, Integrins in cancer: biological implications and therapeutic opportunities, Nature Reviews Cancer, vol.13, issue.1, pp.9-22, 2010.
DOI : 10.1593/neo.08740

P. Marchisio, Changes in Integrin and E-cadherin Expression in Neoplastic Versus Normal Thyroid Tissue, Journal of the National Cancer Institute, vol.88, issue.7, pp.442-449, 1996.

J. Varner, D. Emerson, and R. Juliano, Integrin alpha 5 beta 1 expression negatively regulates cell growth: reversal by attachment to fibronectin., Molecular Biology of the Cell, vol.6, issue.6, pp.725-740, 1995.
DOI : 10.1091/mbc.6.6.725

R. Evans, V. Perkins, A. Henry, P. Stephens, M. Robinson et al., A Tumorassociated Beta 1 Integrin Mutation That Abrogates Epithelial Differentiation Control, The Journal of Cell Biology Feb, vol.17, issue.1604, pp.589-596, 2003.

M. Trikha, Y. Cai, D. Grignon, and K. Honn, Identification of a Novel Truncated alphaIIb

. Integrin, Cancer Research, pp.4771-4775, 1998.

W. Guo and F. Giancotti, Integrin signalling during tumour progression, Nature Reviews Molecular Cell Biology, vol.15, issue.10, pp.816-826, 2004.
DOI : 10.1101/gad.903001

Y. Pylayeva, K. Gillen, W. Gerald, H. Beggs, L. Reichardt et al., Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling, Journal of Clinical Investigation, vol.119, issue.2, pp.252-256, 2009.
DOI : 10.1172/JCI37160DS1

C. Avraamides, B. Garmy-susini, and J. Varner, Integrins in angiogenesis and lymphangiogenesis, Nature Reviews Cancer, vol.99, issue.8, pp.604-617, 2008.
DOI : 10.1172/JCI200422087

C. Papayannopoulou, T. Lowy, A. Blair, S. Cheresh, D. Ginsberg et al., Integrin ?4?1 Signaling Is Required for Lymphangiogenesis and Tumor Metastasis, Cancer Research, vol.70, pp.3042-3051, 2010.

J. Pouysségur, F. Dayan, and N. Mazure, Hypoxia signalling in cancer and approaches to enforce tumour regression, Nature, vol.9, issue.suppl. 5, pp.437-443, 1792.
DOI : 10.1016/j.devcel.2005.09.010

D. N. Louis, H. Ohgaki, O. D. Wiestler, and W. K. Cavenee, WHO Classification of Tumours of the Central Nervous System, Fourth Edition. IARC WHO Classification of Tumours, 2007.

C. Bouvier and C. , Classification histologique et moléculaire des gliomes, Revue Neurologique, vol.164, pp.505-515, 2008.

R. Janzer, Neuropathology and molecular pathology of gliomas

M. Riemenschneider, J. Jeuken, P. Wesseling, and G. Reifenberger, Molecular diagnostics of gliomas: state of the art, Acta Neuropathologica, vol.324, issue.5, pp.567-584, 2010.
DOI : 10.1093/neuonc/nop020

M. Westphal and K. Lamszus, The neurobiology of gliomas: from cell biology to the development of therapeutic approaches, Nature Reviews Neuroscience, vol.18, issue.9, pp.495-508, 2011.
DOI : 10.1111/j.1750-3639.2008.00136.x

E. Halperin, G. Bentel, E. Heinz, and P. Burger, Radiation therapy treatment planning in supratentorial glioblastoma multiforme: An analysis based on post mortem topographic anatomy with ct correlations, International Journal of Radiation Oncology*Biology*Physics, vol.17, issue.6, pp.1347-1350, 1989.
DOI : 10.1016/0360-3016(89)90548-8

P. Wesseling, D. Ruiter, and P. Burger, Angiogenesis in brain tumors; pathobiological and clinical aspects, Journal of Neuro-Oncology, vol.32, issue.3, pp.253-265, 1997.
DOI : 10.1023/A:1005746320099

P. Wen, S. Kesari, F. Ducray, S. Del-rio, M. et al., Malignant Gliomas in Adults, New England Journal of Medicine, vol.359, issue.5, pp.492-507, 2008.
DOI : 10.1056/NEJMra0708126

E. Holland, Gliomagenesis: genetic alterations and mouse models, Nature Reviews Genetics, vol.59, issue.2, pp.120-139, 2001.
DOI : 10.1101/gad.12.23.3675

K. Kil, Y. Ding, and K. Lin, Synthesis and positron emission tomography studies of carbon-11-labeled imatinib (Gleevec), Nuclear Medicine and Biology, vol.34, issue.2, pp.153-63, 2007.
DOI : 10.1016/j.nucmedbio.2006.11.004

S. Uhling, J. Herndon, J. Vredenburgh, J. Sampson, A. Friedman et al., Phase II trial of gefitinib in recurrent glioblastoma, J Clin Oncol, vol.22, issue.1, pp.133-175, 2004.

M. Mcdermott, A. Parsa, S. Vanderberg, C. James, K. Lamborn et al., Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma, J Clin Oncol, 2009.

D. Haber, Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib, N Engl J Med, vol.350, issue.50, pp.2129-2139, 2004.

H. Kletzl, D. Klughammer, D. Lacombe, and T. Gorlia, Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study

K. Yoshimoto, J. Huang, D. Chute, B. Riggs, S. Horvath et al., Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors, N Engl J Med, vol.353, pp.2012-2024, 2005.

A. Brandes, E. Franceschi, A. Tosoni, M. Hegi, and R. Stupp, Epidermal Growth Factor Receptor Inhibitors in Neuro-oncology: Hopes and Disappointments, Clinical Cancer Research, vol.14, issue.4, pp.957-960, 2008.
DOI : 10.1158/1078-0432.CCR-07-1810

A. Omuro, S. Faivre, and R. E. , Lessons learned in the development of targeted therapy for malignant gliomas, Molecular Cancer Therapeutics, vol.6, issue.7, pp.1909-1919, 2007.
DOI : 10.1158/1535-7163.MCT-07-0047

A. Friedman and H. Friedman, Bevacizumab and irinotecan in recurrent malignant glioma, Clin Cancer Res, vol.13, pp.1253-1259, 2007.

S. Sathornsumetee, S. Gururangan, J. Sampson, L. Bailey, D. Bigner et al., Bevacizumab plus irinotecan in recurrent WHO grade 3 malignant gliomas, Clin Cancer Res, vol.14, issue.21, pp.7068-7073, 2008.

G. Zhang, Y. Carson, K. Wittemer, S. Colevas, A. Grossman et al., Phase I and correlative biology study of cilengitide in patients with recurrent malignant glioma, Clin Oncol, 2007.

L. Ebbeling, B. Levy, J. Drappatz, S. Kesari, and P. Wen, Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence, Neurology, vol.70, issue.10, pp.779-787, 2008.

A. Lai, E. Filka, B. Mcgibbon, P. Nghiemphu, C. Graham et al., Phase II Pilot Study of Bevacizumab in Combination with Temozolomide and Regional Radiation Therapy for Up-Front Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Interim Analysis of Safety and Tolerability, International Journal of Radiation Oncology*Biology*Physics, vol.71, issue.5, pp.1372-1380, 2008.
DOI : 10.1016/j.ijrobp.2007.11.068

H. Kretzschmar, J. Tonn, and R. Goldbrunner, Expression of integrin alphavbeta3 in gliomas correlates with tumor grade and is not restricted to tumor vasculature, Brain Pathol, vol.18, issue.3, pp.378-386, 2008.

W. Paulus, I. Baur, D. Schuppan, and W. Roggendorf, Characterization of integrin receptors in normal and neoplastic human brain, Am J Pathol, vol.143, issue.1, pp.154-163, 1993.

D. Branger, L. Ouafik, and J. Luis, Expression of integrin alpha6beta1 enhances tumorigenesis in glioma cells, Am J Pathol, vol.175, issue.2, pp.844-855, 2009.

D. Reardon, L. Nabors, R. Stupp, and T. Mikkelsen, Cilengitide: an integrin-targeting arginine???glycine???aspartic acid peptide with promising activity for glioblastoma multiforme, Expert Opinion on Investigational Drugs, vol.62, issue.8
DOI : 10.1054/bjoc.2000.1316

A. Carter, Integrins as Target: First Phase III Trial Launches, but Questions Remain, JNCI: Journal of the National Cancer Institute, vol.102, issue.10
DOI : 10.1093/jnci/djq186

URL : https://academic.oup.com/jnci/article-pdf/102/10/675/18085466/djq186.pdf

M. Dontenwill, Alpha5beta1 integrin antagonists reduce chemotherapy-induced premature 104

E. Cosset, J. Godet, N. Entz-werlé, E. Guérin, D. Guenot et al., Involvement of TGF? pathway in the regulation of ?(5) ?(1) integrins by caveolin-1 in human glioblastoma, Int J Cancer, 2011.

A. Cohen, R. Hnasko, W. Schubert, and M. Lisanti, Role of Caveolae and Caveolins in Health and Disease, Physiological Reviews, vol.84, issue.4, pp.1341-1379, 2004.
DOI : 10.1073/pnas.172360799

L. Taillandier, L. Antunes, and K. Angioi-duprez, Models for neuro-oncological preclinical studies: solid orthotopic and heterotopic grafts of human gliomas into nude mice, Journal of Neuroscience Methods, vol.125, issue.1-2, pp.147-157, 2003.
DOI : 10.1016/S0165-0270(03)00043-8

K. Livak and T. Schmittgen, Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2???????CT Method, Methods, vol.25, issue.4, pp.402-408, 2001.
DOI : 10.1006/meth.2001.1262

D. Figarella-branger and C. Bouvier, Histological classification of human gliomas: state of art and controversies, Bulletin Du Cancer, vol.92, pp.301-309, 2005.

S. Coons, P. Johnson, B. Scheithauer, A. Yates, and D. Pearl, Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas, Cancer, vol.88, issue.7
DOI : 10.1037/0033-2909.86.5.974

K. Suchiro, J. Mizuguchi, K. Nishiyama, S. Iwagana, D. Farrel et al., Fibrinogen binds to integrin alpha(5)beta(1) via the carboxyl-terminal RGD site of the Alpha-chain, J Biochem, vol.128, issue.4, pp.705-715, 2000.

W. To and K. Midwood, Plasma and cellular fibronectin: distinct and independent functions during tissue repair, Fibrogenesis & Tissue Repair, vol.4, issue.1, p.21, 2011.
DOI : 10.1097/01.ASN.0000051600.53134.B9

URL : http://europepmc.org/articles/pmc3182887?pdf=render

Z. Ruggeri and G. Mendolicchio, Adhesion Mechanisms in Platelet Function, Circulation Research, vol.100, issue.12, pp.1673-1685, 2007.
DOI : 10.1161/01.RES.0000267878.97021.ab

D. Figarella-branger, P. Roche, L. Daniel, H. Dufour, N. Bianco et al., Celladhesion molecules in human meningiomas: correlation with clinical and morphological data

E. Moyal, Alphavbeta3/alphavbeta5 integrins-FAK-RhoB: a novel pathway for hypoxia regulation in glioblastoma, Cancer Research, vol.69, issue.8, pp.3308-3316, 2009.